FDA agrees ENABLE-2 Phase III trial design for Enliven’s relcobatinib
Enliven Therapeutics has reached an agreement with the US Food and Drug Administration (FDA) regarding the final protocol for the…
News
Viking Therapeutics begins study of oral VK2735 for obesity
ViiV Healthcare’s Cabenuva beats daily oral ART in Phase IIIb trial
Eye implant triggers sight improvements in GA at 36-months, pivotal study finds
AbbVie, Genmab report positive results from Phase III EPCORE DLBCL-2 trial
First patient dosed in Vial’s Phase Ib trial of IL-13 x TSLP antibody
Vaxcyte’s stock up after pneumococcal vaccine proves non-inferiority
Clinical trial experts turn to AI and new partnerships to tackle growing trial complexity
